NOILE-IMMUNE BIOTECH INC revenue breakdown overview

NOILE-IMMUNE BIOTECH INC revenue for the last year amounted to 7.00 M JPY, the most of which — 7.59 M JPY — came from its highest performing source at the moment, Cancer Immunotherapy Drug, the year earlier bringing 316.82 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought NOILE-IMMUNE BIOTECH INC 7.59 M JPY, and the year before that — 316.82 M JPY.